These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 30003753)
1. MiR-384 represses tumorigenesis by regulating CDK6 and predicts prognosis of clear cell renal cell carcinoma. Guo L; Wang D; Zhang Z J BUON; 2018; 23(3):787-794. PubMed ID: 30003753 [TBL] [Abstract][Full Text] [Related]
2. Pan H; Hong Y; Yu B; Li L; Zhang X Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301 [No Abstract] [Full Text] [Related]
3. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis. Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014 [TBL] [Abstract][Full Text] [Related]
4. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1. Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471 [TBL] [Abstract][Full Text] [Related]
6. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1. Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425 [TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867 [TBL] [Abstract][Full Text] [Related]
8. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Deng JH; Zheng GY; Li HZ; Ji ZG Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538 [TBL] [Abstract][Full Text] [Related]
9. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066 [TBL] [Abstract][Full Text] [Related]
10. MiR-186 represses progression of renal cell cancer by directly targeting CDK6. Guo Z; Lv X; Jia H Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659 [TBL] [Abstract][Full Text] [Related]
11. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma. Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6. Ma J; Li T; Yuan H; Han X; Shui S; Guo D; Yan L J Cell Biochem; 2018 Mar; 119(3):2617-2626. PubMed ID: 29023945 [TBL] [Abstract][Full Text] [Related]
14. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
15. Propofol Disrupts Clear Cell Renal Cell Carcinoma Tumorigenesis by Regulating circFBXW7/miR-942 Axis. Huang Y; Wu Y; Lu S Nephron; 2022; 146(5):514-527. PubMed ID: 35307709 [TBL] [Abstract][Full Text] [Related]
16. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression. Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660 [TBL] [Abstract][Full Text] [Related]
17. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression. Guo Z; Jia H; Ge J Hum Cell; 2020 Jul; 33(3):750-758. PubMed ID: 32277426 [TBL] [Abstract][Full Text] [Related]
18. MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Xiao H; Zeng J; Li H; Chen K; Yu G; Hu J; Tang K; Zhou H; Huang Q; Li A; Li Y; Ye Z; Wang J; Xu H Oncotarget; 2015 May; 6(15):13201-15. PubMed ID: 26036633 [TBL] [Abstract][Full Text] [Related]
19. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma. Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591 [TBL] [Abstract][Full Text] [Related]
20. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]